UK Sanders-Brown Center on Aging

Researchers at the University of Kentucky are part of a groundbreaking clinical trial exploring the use of medical marijuana in managing symptoms of late-stage dementia. Greg Jicha, M.D., Ph.D., a neurologist and director of clinical trials at UK’s Sanders-Brown Center on Aging,talks with Dr. Greg about the National Institutes of Health-funded and Food and Drug Administration-approved LiBBY Study examining the potential benefits of cannabis-derived treatments for addressing agitation and discomfort in patients with advanced dementia, a population with limited palliative care options.

This week on Dr. Greg Davis on Medicine Dr. Pete Nelson with UK's Sanders Brown Center on Aging talks about this rare form of dementia

The University of Kentucky is a site for the groundbreaking AHEAD study, the first-ever clinical trial to test the effect of a promising drug known as lecanemab. Just a few weeks ago the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. This represents an important advancement in the ongoing fight to effectively treat Alzheimer’s disease, and UK’s Sanders-Brown Center on Aging is on the forefront of the work. Dr. Greg speaks with Greg Jicha, director of clinical trials at UK’s Sanders-Brown Center on Aging.

The University of Kentucky has officially opened a new state-of-the-art facility dedicated to memory care. WUKY’s Karyn Czar reports.

The University of Kentucky is set to take part in a landmark clinical trial on an experimental Alzheimer’s drug. Researchers hope to enroll a thousand…

LEXINGTON, Ky. - Each year around 5,000 babies are born in the United States with Down syndrome, a genetic disorder that can impair mental abilities and…